TrialJournal of neuro-oncology2012

Cilengitide in patients with recurrent glioblastoma: the results of NABTC 03-02, a phase II trial with measures of treatment delivery.

Mark R Gilbert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.